Table 5.
Variables |
E2F1 expression |
Spearman |
χ2 test |
|||||
---|---|---|---|---|---|---|---|---|
−/+ | ++ | +++ | R | P | χ2 | P | ||
Age |
<55 |
7 |
11 |
19 |
0.103 |
0.334 |
1.069 |
0.586 |
≥55 |
8 |
12 |
33 |
|||||
Gender |
Male |
9 |
20 |
39 |
0.038 |
0.725 |
3.193 |
0.166 |
Female |
6 |
3 |
13 |
|||||
Smoking |
Non-smoker |
4 |
3 |
14 |
0.068 |
0.518 |
1.829 |
0.411 |
Smoker |
11 |
20 |
38 |
|||||
Tumor size |
<4 cm |
9 |
12 |
35 |
0.105 |
0.325 |
1.592 |
0.451 |
≥4 cm |
6 |
11 |
17 |
|||||
Clinical stage | LD* |
13 |
10 |
7 |
0.552 | < 0.01 | 29.506 | <0.01 |
ED* | 2 | 13 | 45 |
−/+ represents E2F1 weak expression, ++ represents E2F1 moderate expression, +++ represents E2F1 higher expression, LD* represents limited disease and ED* represents extensive disease.